|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2003-12-17
|
|
pubmed:abstractText |
Nonalcoholic steatohepatitis (NASH) is a serious disorder with the potential to gradually progress to cirrhosis. It is generally associated with obesity, diabetes and hyperlipidemia. Currently, there is no established therapy for NASH. The aim of the present study was to evaluate the effectiveness of atorvastatin and ursodeoxycholic acid (UDCA) in the treatment of NASH.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0835-7900
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
713-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14679419-Adult,
pubmed-meshheading:14679419-Anticholesteremic Agents,
pubmed-meshheading:14679419-Fatty Liver,
pubmed-meshheading:14679419-Female,
pubmed-meshheading:14679419-Hepatitis,
pubmed-meshheading:14679419-Heptanoic Acids,
pubmed-meshheading:14679419-Humans,
pubmed-meshheading:14679419-Male,
pubmed-meshheading:14679419-Middle Aged,
pubmed-meshheading:14679419-Prospective Studies,
pubmed-meshheading:14679419-Pyrroles,
pubmed-meshheading:14679419-Ursodeoxycholic Acid
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis.
|
|
pubmed:affiliation |
Department of Gastroenterology, Uludag University, Bursa, Turkey. mkiyici@uludag.edu.tr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study
|
